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length of Xenopus oocyte lampbrush chromosomes, co-School of Medicine and Dentistry
University of Rochester incident with RNA polymerase II staining (Gall et al.,
1999). Somewhat unexpectedly, RNA polymerase II alsoRochester, New York 14642
†Department of Microbiology functions in mRNA QC by playing a direct and active
role in splicing and 39 end formation in the absence ofUniversity of Connecticut Health Center
Farmington, Connecticut 06030 transcription (Hirose and Manley, 2000, and references
therein).
The major steps of pre-mRNA processing appear to
be coupled to each other as well, a feat also thought to
Most eukaryotic cellular proteins are generated by trans-
be orchestrated by the CTD as an additional measure
lation of mRNAs that have successfully passed a number
of QC. Efficient capping enhances both splicing and 39
of steps to insure their quality. Transcripts that fail to
end formation, and efficient 39 end formation enhances
pass selection are degraded or otherwise prevented
splicing (Hirose and Manley, 2000, and Proudfoot, 2000,
from engaging in protein synthesis. Recent studies have
and references therein). Recent studies of Saccharo-
begun to elucidate the molecular mechanisms responsi-
myces cerevisiae have uncovered a nuclear discard
ble for the pre- and cotranslational quality control (QC) of
pathway for inefficiently spliced pre-mRNAs that ap-
mRNA and the consequence to organisms when control
pears to function in competition with the splicing path-
fails. mRNA QC reflects physical interactions between
way (Bousquet-Antonelli et al., 2000). Transcripts are
components of the gene transcription, pre-mRNA pro-
degraded primarily in a 39 to 59 direction by the exosome,
cessing, mRNA transport, and mRNA translation ma-
but can also be degraded 59 to 39 by Rat1p. Both the
chineries. These interactions insure against transcript
exosome and Rat1p have orthologs in mammals, sug-
degradation when interactions are timely and proper,
gesting that similar modes of degradation exist in higher
but elicit nuclear retention of the transcript, or degrada-
eukaryotes. In light of recent data demonstrating that
tion in the nucleus or cytoplasm, when interactions are
transcription termination requires a poly(A) signal but
delayed or abnormal.
not transcript cleavage (Hirose and Manley, 2000, andGene Transcription, and Pre-mRNA Synthesis
Proudfoot, 2000, and references therein), it is conceiv-and Processing
able that this discard pathway also eliminates tran-
mRNA QC begins at the level of gene transcription. The
scripts that undergo inefficient 39 end formation.
cotranscriptional nature of pre-mRNA processing offers
mRNA Export
a number of opportunities for transcription to affect the
After pre-mRNA processing, product mRNAs are ex-
quality and quantity of mRNA. Evidence that the transcrip-
ported to the cytoplasm. Export offers yet another
tional machinery can regulate pre-mRNA processing de-
form of mRNA QC because it is a selective and active
rives in part from the finding that sequence changes in
process that discriminates between immature and ma-
the human fibronectin promoter can alter splice site
ture mRNP. mRNA export is attributable to bound pro-
selection, possibly through the differential recruitment
teins that promote export, many of which are acquired
of splicing factors, in this case SR proteins SF2/ASF
as a consequence of pre-mRNA processing, and can
and 9G8, to the CTD, the carboxyl terminal domain of
be inhibited by bound proteins that block export, some
the largest subunit of RNA polymerase II (Cramer et al.,
of which are the consequence of incomplete pre-mRNA
1999). As additional evidence, the transcription factor
TFIID recruits the 39 end formation factor CPSF to pro-
moters, where it is subsequently transferred to the CTD
so as to direct endonucleolytic cleavage of nascent tran-
scripts followed by polyadenylation of the upstream
cleavage product (see, e.g., Hirose and Manley, 2000,
and references therein). In fact, an abundance of data
indicate that the CTD not only functions to regulate as-
pects of gene transcription, especially initiation, but also
functions in association with factors required for pre-
mRNA capping, splicing, and 39 end formation to coordi-
nate pre-mRNA synthesis and processing throughout
transcription initiation, elongation, and termination (Fig-
Figure 1. Coordinate Gene Transcription and pre-mRNA Pro-
ure 1) (Hirose and Manley, 2000, and Proudfoot, 2000, cessing
and references therein). Providing perhaps the most The carboxyl terminal domain (CTD) of the largest subunit of RNA
striking visual evidence for the QC of mRNA formation polymerase II (RNAP II) is associated with pre-mRNA processing
factors during transcription initiation, elongation, and termination.
These factors then associate with and process nascent RNA to
generate mRNA. As a consequence of mRNA QC, errors in these‡ E-mail: lynne_maquat@urmc.rochester.edu (L. E. M.); gcarmich@
neuron.uchc.edu (G. G. C.). processes can lead to RNA nuclear retention, degradation, or both.
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(LeHir et al., 2000). mRNAs that derive from genes that
naturally lack introns might co-opt some of the same
factors used for the export of spliced mRNAs, or they
may use a different pathway.
mRNA Translation
QC is also exerted during mRNA translation, another
selective and active process that discriminates between
improper and proper mRNP. Generally, the cap and
poly(A) tail of an mRNA contribute to cytoplasmic stabil-
ity, presumably by stimulating translation and, thereby,
physically protecting the mRNA from accessibility to
nucleases (see, e.g., Mitchell and Tollervey, 2000, and
references therein). A different type of translational QC
is thought to survey all translated mRNAs in order to
prevent the synthesis of proteins from those that prema-
turely terminate translation as a consequence of errors
in gene expression. Errors include aberrant transcription
Figure 2. A Model for mRNA Export to the Cytoplasm initiation, inaccurate or inefficient splicing, the failure to
mRNA molecules in the nucleus are bound by a variety of factors, incorporate selenocysteine at specific UGA codons of
some which promote export, and some which block export and certain selenoprotein mRNAs, and frameshift or non-
which must be removed prior to translocation through the pore.
sense mutations within germ-line or somatic DNA. ThisTransport most likely occurs in a 59-to-39 direction.
QC mechanism has been called nonsense-mediated
mRNA decay (NMD) or mRNA surveillance. NMD is, in
essence, the downregulation of mRNA translation andprocessing (see, e.g., Nakielny and Dreyfuss, 1999, and
activation of mRNA decapping and degradation as areferences therein). Defects in capping, splicing, and 39
consequence of the premature termination of translationend formation inhibit export in both S. cerevisiae and
(see, e.g., Jacobson and Peltz, 2000, and Maquat, 2000,mammalian cells (Nakielny and Dreyfuss, 1999, and ref-
and references therein).erences therein). Roles for mature 59 and 39 ends, cou-
NMD in S. cerevisiae is thought to take place in thepled with electron microscopic analysis of Balbiani ring
cytoplasm. The trigger has been proposed to be anmRNPs in the process of export (Daneholt, 1997), have
abnormal 39-untranslated region, possibly reflecting anled to a model where export is promoted by recognition
abnormal distance between a termination codon andof both ends of an mRNP at the nuclear pore. According
the site of polyadenylation or, according to an alternativeto this model, failure to recognize either end would signal
view, the presence of a loosely defined destabilizingthe presence of an aberrant particle, which would retard
element (Jacobson and Peltz, 2000, and referencesexport (Figure 2).
therein). The destabilizing element is hypothesized to
But proper capping and 39 end formation are not suffi-
recruit one of a number of shuttling proteins, e.g., Hrp1p,
cient to insure mRNA export, as would be expected
in the nucleus that, if located downstream of a termina-
since they are also characteristic of a number of incom-
tion codon, interacts with components of the translation
pletely spliced pre-mRNAs. Factors that block export, termination complex in the cytoplasm in a way that elic-
such as some components of spliceosomes and other its NMD. In contrast, NMD in mammalian cells can take
non-shuttling proteins, must be removed. For example, place either in the cytoplasm or in association with nu-
COL1A1 transcripts defective in splicing initiate trans- clei, and is generally triggered by a larger than 50 to 55
port away from their site of synthesis but subsequently nucleotide distance between a termination codon and
accumulate to abnormal levels within a nuclear domain a downstream exon–exon junction (Maquat, 2000, and
rich in the SC-35 splicing factor (Johnson et al., 2000, references therein). The sensitivity of NMD to inhibitors
and references therein). Additionally, the transport of of translation, regardless of the cellular site, has led
many if not most mRNAs appears to reflect the binding to the proposal that nucleus-associated NMD reflects
of shuttling hnRNP and perhaps SR proteins (Nakielny assessment of the translational reading frame either dur-
and Dreyfuss, 1999, and references therein) as well as ing the export of nuclear mRNA to the cytoplasm by
a direct coupling of pre-mRNA splicing and mRNA ex- cytoplasmic ribosomes or prior to export by a mecha-
port via splicing-dependent changes in mRNP structure. nism that must somehow be related to cytoplasmic
Recent studies have revealed that the general mRNA ex- translation. The dependence of NMD on the distance
port factor Aly is recruited to pre-mRNA during spliceo- between the termination codon and a downstream
some assembly and subsequently becomes tightly associ- exon–exon junction has been explained by a splicing-
ated with spliced mRNPs in a way that promotes mRNP dependent alteration to mRNP that elicits QC by inter-
export (Zhou et al., 2000). Aly (also called REF) and Y14, acting with components of the translation termination
another protein implicated indirectly in mRNA export, complex. It is reasonable to think that such an alteration
have been shown to be components of an <335 kDa could be or could depend on one or more of the splicing-
splicing-dependent complex centered 20–24 nucleo- dependent proteins that bind 20–24 nt upstream of
tides upstream of the exon–exon junctions of mRNPs exon–exon junctions, as discussed above.
generated by splicing in HeLa cell nuclear extract (Le Currently, the most likely alteration to mRNP that func-
Hir et al., 2000, and references therein). A similar mRNP tions directly in NMD in human cells is the association
of one of the recently described human Upf3 proteinscomplex is generated by splicing in Xenopus oocytes
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Figure 4. The Fate of dsRNA in the Nucleus
Long duplexes lead to extensive editing and nuclear retention. ShortFigure 3. A Model for Nonsense-Mediated mRNA Decay (NMD),
duplexes lead to edited mRNAs that can be exported to the cyto-also Called mRNA Surveillance, in the Cytoplasm of Mammalian
plasm.Cells
The dotted gray vertical line in 3) specifies the 39-most exon–exon
junction of mRNA. Nucleus-associated NMD follows a similar path- infection, nuclear dsRNA is extensively modified, pre-
way, but most probably takes place either in the nucleoplasm, in-
sumably by ADAR. Roughly 50% of the A residues involving an uncharacterized translation-like mechanism, or during
duplex regions are converted to I residues. HypereditedmRNA export, involving cytoplasmic translation as shown here for
molecules can be polyadenylated and are relatively sta-cytoplasmic NMD. “Pre Ter” specifies a premature termination co-
don. “Norm Ter” specifies the normal termination codon. “eRF” ble, but they fail to be exported to the cytoplasm (Figure
specifies eukaryotic release factor. 4; see, e.g., Carmichael et al., 2000, and references
therein). The nuclear retention and eventual nuclear deg-
radation of hyperedited RNAs provide a critical means(Figure 3). These proteins shuttle between nuclei and
for QC, since these RNAs, if exported and translated,the cytoplasm, are far more abundant in the nucleus
would produce highly mutated proteins. It is temptingthan the cytoplasm, and are orthologous to a protein
to speculate that retention may be mediated by the » 60required for NMD in S. cerevisiae (Lykke-Andersen et
kDa nuclear protein recently shown to bind extensivelyal., 2000; Serin et al., 2001). In support of this idea, each
edited RNA in a sequence-independent, but highly co-human Upf3 protein associates selectively with spliced
operative manner (Carmichael et al., 2000, and refer-mRNA in vivo, and the tethering of human Upf3 protein
ences therein). In contrast to long duplexes, short RNA(or either human Upf1 or Upf2 protein, which interact
duplexes appear to be substrates for specific editingwith human Upf3 protein) more than 50 to 55 nucleotides
events that do not result in nuclear retention and, con-downstream of a normal termination codon can func-
sidering that I is recognized as guanosine (G) by thetionally replace the splicing-dependent alteration re-
cellular translation machinery, produce specifically al-quired for NMD (Lykke-Andersen et al., 2000).
tered proteins (Figure 4; see, e.g., Bass, 1997, and refer-Response to dsRNA
ences therein).When both the coding and noncoding strands of an RNA
In higher eukaryotes, the QC pathway for cytoplasmicare produced simultaneously in the cell, the potential
dsRNA is primarily an antiviral defense pathway that isexists for the formation of double-stranded (ds) RNA. It is
quite distinct from the QC pathway for nuclear dsRNApossible that many complementary RNAs are expressed
(Figure 5). Uninfected mammalian cells rarely expresswithin the nucleus, either by design (as exemplified by
dsRNA within the cytoplasm, most likely because of theregulatory antisense transcripts) or by transcriptional
ensuing dramatic effects on RNA levels, inhibition ofread-through (as exemplified by the extension of tran-
protein synthesis, and, if prolonged, cell death (see, e.g.,scription from one gene into the antisense strand of an
adjacent gene). The most likely fate of such dsRNA is
QC by RNA editing.
Nuclear dsRNA is a substrate for members of the class
of enzymes known as adenosine deaminases that act
on RNA (ADARs; see e.g., Bass, 1997, and references
therein), first discovered in Xenopus. ADAR1 is ubiqui-
tous in the animal kingdom. Under most conditions, it
is almost exclusively confined to the nucleus. ADARs
catalyze the conversion of adenosine (A) to inosine (I)
within dsRNA. The resulting RNA contains I-U (uridine)
base pairs that make the RNA duplex unstable, and may
lead to partial or complete unwinding.
ADAR editing of dsRNA is sensitive to duplex length.
Duplexes of less than 15 base pairs are not edited in Figure 5. The Fate of dsRNA in the Cytoplasm
vitro, and maximal editing activity is observed with RNA duplexes can induce interferon, activate PKR, and activate
RNase L.dsRNAs of about 100 base pairs. During polyoma virus
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Daneholt, B. (1997). Cell 88, 585–588.Kumar and Carmichael, 1998, and references therein).
Gall, J.G., Bellini, M., Wu, Z., and Murphy, C. (1999). Mol. Biol. CellMost virus infections or other means of generating cyto-
10, 4385–4402.plasmic dsRNA induce type I interferons (IFNs), includ-
Hirose, Y., and Manley, J.L. (2000). Genes Dev. 14, 1415–1429.ing IFN-a and IFN-b. IFNs are multifunctional cytokines
Jacobson, A., and Peltz, S.W. (2000). In Translational Control of Genethat modulate host immunological functions and can
Expression, N. Sonenberg, J.W.B. Hershey, and M.B. Mathews, eds.inhibit tumor cell growth and virus multiplication. A cen-
(Cold Spring Harbor Press: Cold Spring Harbor, NY), pp. 827–847.tral player in cytoplasmic dsRNA activity is the dsRNA-
Johnson, C., Primorac, D., McKinstry, M., McNeil, J., Rowe, D., andactivated protein kinase, PKR. Cells normally contain
Lawrence, J.B. (2000). J. Cell Biol. 150, 417–432.
basal levels of PKR, but in an unphosphorylated and
Kumar, M., and Carmichael, G.G. (1998). Microbiol. Mol. Biol. Rev.
inactive form. Cytoplasmic dsRNA generates auto- 62, 1415–1434.
phosphorylated PKR that can phosphorylate a number
Le Hir, H., Izaurralde, E., Maquat, L.E., and Moore, M.J. (2000). EMBO
of substrates, including eIF2a, which inhibits protein J. 19, 6860–6869.
synthesis. Cytoplasmic dsRNA and IFNs also activate Lykke-Andersen, J., Shu, M.D., and Steitz, J.A. (2000). Cell 103,
the 29, 59-adenylate synthase (AS)/RNase L pathway so 1121–1131.
that 29,59-AS polymerizes ATP and other nucleotides in Maquat, L.E. (2000). In Translational Control of Gene Expression, N.
29,59 linkages (Figure 5; Kumar and Carmichael, 1998, Sonenberg, J.W.B. Hershey, and M.B. Mathews, eds. (Cold Spring
Harbor Press: Cold Spring Habor, NY), pp. 849–868.and references therein). These 29,59 oligoadenylates
then activate the ribonuclease RNase L. RNase L can Mitchell, P., and Tollervey, D. (2000). Curr. Opin. Genet. Dev. 10,
193–198.cleave both cellular and viral RNAs, although its primary
Nakielny, S., and Dreyfuss, G. (1999). Cell 99, 677–690.function in vivo remains to be determined. As far as is
Proudfoot, N. (2000). Trends Biochem. Sci. 25, 290–293.known, dsRNA within the nucleus does not trigger the
IFN, PKR or 29-59-AS pathways. Serin, G., Gersappe, A., Black, J.D., Aronoff, R., and Maquat, L.E.
(2001). Mol. Cell. Biol. 21, 209–223.In cells where the above pathways are inactive, or in
Svoboda, P., Stein, P., Hayashi, H., and Schultz, R.M. (2000). Devel-lower eukaryotes, a separate pathway, RNA interference
opment 127, 4147–4156.(RNAi), might provide the primary QC mechanism to
Zhou, Z., Lou, M.-j., Straesser, K., Katahira, J., Hurt, E., and Reed,eliminate cytoplasmic dsRNAs. In RNAi, dsRNA silences
R. (2000). Nature 407, 401–405.gene expression through the specific degradation of its
cognate mRNA (see, e.g., Bass, 2000, and references
therein). Although RNAi has been reported in mouse
embryos (see, e.g., Svoboda et al., 2000), these cells
have not been reported to contain active PKR, and there
is no evidence that RNAi ever works in mammalian cells
where the more common PKR pathway is active. We
speculate that in most mammalian cells the PKR path-
way might be dominant over the RNAi pathway, or the
RNAi pathway might be lacking altogether.
Future Directions
While individual nuclear and cytoplasmic reactions re-
quired for the formation of functional mRNA can be
carried out in isolation in vitro, it has become increas-
ingly clear that many of the steps along the path from
gene to protein are, in vivo, interdependent in a way that
provides important mechanisms for the QC of mRNA
function. In fact, nothing less would be expected of an
efficiently operating assembly line, which should discard
defective products rather than proceed to process them.
Owing to space and reference constraints, this minire-
view describes neither the bulk of data demonstrating
the interdependence of reactions required for mRNA
biosynthesis, nor the finer details of these reactions.
Future work will no doubt reveal the complete network
of integrated events that ensures mRNA QC and yet-to-
be-defined molecular constituents of this network.
Selected Readings
Bass, B.L. (1997). Trends Biochem. Sci. 22, 157–162.
Bass, B.L. (2000). Cell 101, 235–238.
Bousquet-Antonelli, C., Presutti, C., and Tollervey, D. (2000). Cell
102, 765–775.
Carmichael, G.G., Kumar, M., and Zhang, Z. (2000). Blood Cells.
Mol. Dis. 26, 57–58.
Cramer, P., Ca´ceres, J.F., Cazalla, D., Kadener, S., Muro, A.F.,
Baralle, F.E., and Kornblihtt, A.R. (1999). Mol. Cell 4, 251–258.
